Orthopaedic Implant Company receives FDA clearance for high-value dorsal spanning plate

The Orthopaedic Implant Company has announced FDA clearance and commercial launch of its high-value dorsal spanning plate, adding to the trauma implant portfolio of the company, according to a press release.
The high-value dorsal spanning plate can be used in conjunction with the DRPx distal radius plating system from the company to improve outcomes for patients with wrist fractures, according to the release.
“If we want value-based care to work, then implant companies have to play their part,” Itai Nemovicher, president and CEO of Orthopaedic Implant Company, said in the release. “The

The Orthopaedic Implant Company has announced FDA clearance and commercial launch of its high-value dorsal spanning plate, adding to the trauma implant portfolio of the company, according to a press release.
The high-value dorsal spanning plate can be used in conjunction with the DRPx distal radius plating system from the company to improve outcomes for patients with wrist fractures, according to the release.
“If we want value-based care to work, then implant companies have to play their part,” Itai Nemovicher, president and CEO of Orthopaedic Implant Company, said in the release. “The